FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old
[ad_1]
An infant vaccine is administered by a vaccinator to treat COVID-19, a Pfizer BioNTech virus disease, in Lansdale (PA), U.S.A, December 5, 2021.
Hannah Beier | Reuters
Tuesday’s approval by the Food and Drug Administration for a Pfizer booster dosage for children aged 5-11 years was granted.
The FDA head for vaccines Dr. Peter Marks said that the effectiveness of vaccines decreases with time. Marks stated that vaccine effectiveness declines over time and the FDA believes there are more benefits to a third dose for children aged 5-11 years.
Robert Califf of FDA said that while Covid can be more severe in children, it has been reported to have increased rates in kids being hospitalized and sickened since the introduction of the omicron version in the U.S.
This is important breaking news. Keep checking back for more updates.
[ad_2]